JamesJWhalenMDMEDICAL RESEARCH

Psychiatry • Lincoln, RI

Addiction, Forensic Psychiatry, Geriatric Psychiatry

LINCOLN RESEARCH

Join to view full profile

Dr. Whalen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Whalen's full profile

Already have an account?

Office
6 Blackstone Valley Pl
Bldg 4 Suite 401
Lincoln, RI 02865
Phone+1 401-333-3435

Fax+1 401-333-6434

Education & Training

Massachusetts General Hospital/McLean Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Addiction Psychiatry, 1994
Butler Hospital/Brown UniversityResidency, Psychiatry, 1989 - 1993
The Warren Alpert Medical School of Brown UniversityClass of 1989

Certifications & Licensure

HI State Medical License 2020 - 2026
RI State Medical License 1993 - 2026
MA State Medical License 1991 - 2025
CT State Medical License 2008 - 2023
NH State Medical License 2021 - 2023
NY State Medical License 2021 - 2023
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01
Completed
Phase 3
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01
Completed
Phase 2
Join now to see all